News
Events
Research
Ways to help
About us
Contact Us
DONATE NOW
EVENTS
ANNUAL BALL
CONTACT US
SIGN UP TO NEWSLETTER
Jun 2014
Predicting MS in children
Oct 2014
Three new Incubator Grants announced
Dec 2014
2015 Funding announced
Mar 2015
Investigating new treatment options
Oct 2015
Progress in MS Research Conference
Feb 2016
2016 Round of Funding
Feb 2014
New projects being funded
Feb 2014
Breakthrough study shows great promise

Incubator Grant

The Foundation is pleased to announce the following Incubator Grant has been approved for funding:

What is driving neuromyelitis optica?

Investigators:

Dr Ben Crossett, University of Sydney         
Associate Professor Michael Barnett, University of Sydney

Dr Ben Crossett and Associate Professor Michael Barnett have received incubator grant support to pursue analysis using state-of-the-art techniques exploring the protein fragments that are displayed on the surface of cells in the body. The immune system recognises and responds to these fragments in order to generate an immune response to foreign molecules, or an autoimmune response. They are thought to play an important role in distinguishing ‘self’ and ‘non-self’ which breaks down in MS and also in neuromyelitis optica (NMO).

Around 70% of people with NMO have antibodies to a ‘self’ protein called aquaporin-4 (AQP4), this is a key distinguishing factor between NMO and MS. However, the remaining 30% have clinical signs of NMO but no AQP4 antibodies. It is not clear whether this group represents a variant of MS, a different subtype of NMO, or an entirely new disease entity.

Dr Crossett’s study will use specialised analysis techniques to compare groups of people with NMO (with or without AQP4 antibodies), and people with MS, to identify any differences in the type or amount of protein fragments that are displayed on cell surfaces. This will help to identify if the cell surface proteins could potentially be important in the failure of the immune system to identify ‘self’ and ‘non-self’ in MS and NMO disorders.

The findings of this study will not only help to increase our understanding of immune system function and how the immune system responds to protein fragments on cell surfaces, but will also help to develop a better understanding of the abnormalities in these autoimmune disorders and how they are defined. This knowledge can then form the basis for better diagnostic markers and potentially the development of novel, targeted therapies.    

 

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.